Ipamorelin
Longevity SupportPulsatile GH restoration; IGF-1 axis support; lean mass preservation; sleep architecture improvement
CJC-1295 (No DAC)
Longevity SupportGHRH receptor stimulation; GH pulse amplification; IGF-1 axis restoration
Clinical Decision Framework
When evaluating Ipamorelin versus CJC-1295 (No DAC) for biological age reduction, the primary consideration is the specific hallmark of aging being targeted. While both compounds offer systemic healthspan benefits, their mechanisms of action are distinct.
When to prioritize Ipamorelin:
Select Ipamorelin when the primary clinical objective aligns with its core mechanism: selective ghrelin receptor (ghsr) agonist that stimulates pulsatile gh release with minimal effect on cortisol or prolactin.. This is particularly relevant for protocols focused on selective gh release with a favorable safety profile and minimal side effects..
When to prioritize CJC-1295 (No DAC):
Conversely, CJC-1295 (No DAC) is the superior choice when targeting short-acting ghrh analog (mod grf 1-29) that stimulates pulsatile gh release mimicking natural physiological rhythms., making it the preferred agent for pulsatile gh release that mimics natural gh secretion patterns..
Begin Your Age Reversal Protocol for Ipamorelin or CJC-1295 (No DAC)
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing